Title: Pharmacovigilance and Drug Safety Software Market worth $154.1 Million by 2019
1MarketsandMarkets Presents
Pharmacovigilance and Drug Safety Software Market
worth 154.1 Million by 2019
http//www.marketsandmarkets.com/Market-Reports/dr
ug-safety-pharmacovigilance-software-market-168317
14.html
2The report Pharmacovigilance and Drug Safety
Software Market by Functionality (Adverse Event
Reporting, Fully Integrated Software), Delivery
Mode (On-premise, On-demand/Cloud based (SAAS)),
End-user (Pharma Biotech Companies, CROs, BPOs)
- Global Forecast to 2019 analyzes and studies
the major market drivers, restraints,
opportunities, and challenges in North America,
Europe, Asia-Pacific, and the Rest of the world
(RoW). Browse 74 market data tables and 57
figures spread through 210 pages and in-depth TOC
on Pharmacovigilance and Drug Safety Software
Market by Functionality (Adverse Event Reporting,
Fully Integrated Software), Delivery Mode
(On-premise, On-demand/Cloud based (SAAS)),
End-user (Pharma Biotech Companies, CROs, BPOs)
- Global Forecast to 2019 http//www.marketsandm
arkets.com/Market-Reports/drug-safety-pharmacovigi
lance-software-market-16831714.html
http//www.marketsandmarkets.com/Market-Reports/dr
ug-safety-pharmacovigilance-software-market-168317
14.html
3 Early buyers will receive 10 customization on
this report.
http//www.marketsandmarkets.com/Market-Reports/dr
ug-safety-pharmacovigilance-software-market-168317
14.html
4- The global pharmacovigilance and drug safety
software market is poised to grow at a CAGR of
6.5 during 2014-2019, and is expected to reach a
value of 154.1 Million in 2019. - In this report, the global pharmacovigilance and
drug safety software market has been classified
into many segments on the basis of functionality,
namely, adverse event reporting software, drug
safety audits software, issue tracking software,
and fully integrated software.
http//www.marketsandmarkets.com/Market-Reports/dr
ug-safety-pharmacovigilance-software-market-168317
14.html
5-
- The global pharmacovigilance and drug safety
software market is divided into two segments on
the basis of delivery mode, namely, on-premise
delivery mode and on-demand/cloud based (SaaS)
delivery mode. The global pharmacovigilance and
drug safety software market is also segmented on
the basis of end users including pharma and
biotech companies, contract research
organizations (CROs), business process
outsourcing (BPO) firms, and other
pharmacovigilance service providers.
http//www.marketsandmarkets.com/Market-Reports/dr
ug-safety-pharmacovigilance-software-market-168317
14.html
6- Factors such as rising incidence rates of adverse
drug reactions (ADRs) and increasing adoption of
pharmacovigilance software by outsourcing
companies are driving the growth of the global
pharmacovigilance and drug safety software
market. In addition government regulatory bodies
(such as the U.S. FDA and EMEA) have intensified
safety regulations for prior and post
commercialization of drugs, which has increased
pressure on the pharmaceutical and biotechnology
companies to manufacture safe drugs and evaluate
their results post sales. Thus, growing
complexity related to drug safety regulations is
expected to drive the growth of the market during
the forecast period.
http//www.marketsandmarkets.com/Market-Reports/dr
ug-safety-pharmacovigilance-software-market-168317
14.html
7- As of 2014, North America holds the largest share
of the global pharmacovigilance and drug safety
software market, followed by Europe. However,
Asian and Latin American countries represent high
growth markets, owing to a rise in research
outsourcing by pharmaceutical giants and growing
public and private investments in pharmaceutical
RD in these emerging nations.
http//www.marketsandmarkets.com/Market-Reports/dr
ug-safety-pharmacovigilance-software-market-168317
14.html
8- ArisGlobal (U.S.), Ennov Solutions Inc. (U.S.),
EXTEDO GmbH (U.S.), Online Business Applications,
Inc. (U.S.), Oracle Corporation (U.S.), Sarjen
Systems Pvt. Ltd (India), Sparta Systems, Inc.
(U.S.), and United BioSource Corporation (U.S.)
are some of the key players in the global
pharmacovigilance and drug safety software market.
http//www.marketsandmarkets.com/Market-Reports/dr
ug-safety-pharmacovigilance-software-market-168317
14.html
9Contact Us
Contact Mr. Rohan Markets and Markets UNIT no
802, Tower no. 7, SEZ Magarpatta city,
Hadapsar Pune, Maharashtra 411013,
India 1-888-600-6441 Email sales_at_marketsandmarket
s.com
http//www.linkedin.com/company/marketsandmarkets
http//www.marketsandmarkets.com/Market-Reports/dr
ug-safety-pharmacovigilance-software-market-168317
14.html
10About MarketsandMarkets
MarketsandMarkets is the global market research
and consulting company based in the U.S. We
publish strategically analyzed market research
reports and serve as a business intelligence
partner to Fortune 500 companies across the
world. MMs flagship competitive intelligence
and market research platform, "RT" connects over
200,000 markets and entire value chains for
deeper understanding of the unmet insights along
with market sizing and forecasts of niche
markets. The new included chapters on Methodology
and Benchmarking presented with high quality
analytical infographics in our reports gives
complete visibility of how the numbers have been
arrived and defend the accuracy of the
numbers. We at MarketsandMarkets are inspired
to help our clients grow by providing apt
business insight with our huge market
intelligence repository.
http//www.marketsandmarkets.com/Market-Reports/dr
ug-safety-pharmacovigilance-software-market-168317
14.html